← Leaderboards
David M. Neskey
Medical University Of South Carolina
$709,377
Attributed
$1,013,754
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $505.2K · FY2016–21$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,013,754 · 3
By mechanism
K08$405,000 · 1
R21$327,783 · 1
K12$280,971 · 1
Top collaborators
- Chrystal Mary Paulos2 shared
- John M. Wrangle1 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Chrystal Mary Paulos$6,163,426
- Besim Ogretmen$19,638,711
- Megan M Wyatt$531,713
- Richard David Sentelle$190,844
- Peggi M Angel$7,583,294
Others in their field
Top investigators on “Scientist”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Mitchell J Malone · Texas A&M Research Foundation$329,191,208
- David Heimbrook · Leidos Biomedical Research, Inc.$322,837,216
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ScientistCancer CenterMalignant NeoplasmsCellsSurgeonTumorMigrationHigh RiskMediatingImproved OutcomePathway InteractionsHead And Neck CancerUniversitiesSouth CarolinaSolid NeoplasmProgramsMedicalNext GenerationResearch PersonnelFundingResearch TrainingPatient PopulationCancer DiagnosisAnti-Pd1 Therapy
Grant awards (6)
Defining the role of CD26 in checkpoint blockaded induced tumor immunity$103,533
R21 · FY2021 · DE · contact PI
MUSC/HCC Paul Calabresi Clinical Oncology Career Development Program$280,971
K12 · FY2020 · CA
Defining the role of CD26 in checkpoint blockaded induced tumor immunity$224,250
R21 · FY2020 · DE · contact PI
The tumor suppressor capability of p53 is dependent on Non-muscle Myosin IIA function in Head and Neck Cancer.$135,000
K08 · FY2018 · DE · contact PI
The tumor suppressor capability of p53 is dependent on Non-muscle Myosin IIA function in Head and Neck Cancer.$135,000
K08 · FY2017 · DE · contact PI
The tumor suppressor capability of p53 is dependent on Non-muscle Myosin IIA function in Head and Neck Cancer.$135,000
K08 · FY2016 · DE · contact PI